Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptionally distinct malignant neuroblastoma populations show selective response to adavosertib treatment. | Neurotherapeutics | 2025 | 40118716 | PubTator, text mining | PubMed |
| UBE2C mediates follicular thyroid carcinoma invasion and metastasis via K29-Specific vimentin ubiquitination. | Cancer Lett | 2025 | 40074069 | PubTator, text mining | PubMed |
| Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance. | Mol Oncol | 2025 | 40009518 | PubTator, text mining | PubMed |
| Prognostic Significance of CDK1 in Ovarian and Cervical Cancers. | J Cancer | 2025 | 39991589 | PubTator, text mining | PubMed |
| UBE2C regulating the lung carcinoma progression via inhibiting ubiquitin-proteasomal degradation to increase MMP9 protein stability. | Genes Genomics | 2025 | 39976649 | PubTator, text mining | PubMed |
| Machine learning-based identification of co-expressed genes in prostate cancer and CRPC and construction of prognostic models. | Sci Rep | 2025 | 39956870 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis to explore potential therapeutic targets and drugs for small cell carcinoma of the esophagus. | Front Bioinform | 2025 | 39944135 | PubTator, text mining | PubMed |
| Statistical and machine learning based platform-independent key genes identification for hepatocellular carcinoma. | PLoS One | 2025 | 39908244 | PubTator, text mining | PubMed |
| Deciphering the senescence-based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel bulk and single-cell transcriptome data. | IUBMB Life | 2025 | 39865528 | PubTator, text mining | PubMed |
| Study of urine-based mRNA biomarkers for early detection of nonmuscle invasive bladder cancer (NMIBC). | Urol Oncol | 2025 | 39800632 | PubTator, text mining | PubMed |
Deciphering potential molecular mechanisms in clear cell renal cell carcinoma based on the ubiquitin-conjugating enzyme E2 related genes: Identifying UBE2C correlates to infiltration of regulatory T cells. | Biofactors | 2025 | 39614426 | PubTator, text mining | PubMed |
| Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers. | Prostate Cancer Prostatic Dis | 2025 | 39543244 | PubTator, text mining | PubMed |
| Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway. | Chin Med J (Engl) | 2025 | 39307934 | PubTator, text mining | PubMed |
| Anti-tumor effects of nanosecond pulsed electric fields in a murine model of pancreatic cancer. | Bioelectrochemistry | 2025 | 39241512 | PubTator, text mining | PubMed |
| Therapeutic Potential of PLK1, KIF4A, CDCA5, UBE2C, CDT1, SKA3, AURKB, and PTTG1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression with Sensitivity to GSK 461364 and IKK 16 Drugs. | Biochem Genet | 2025 | 39214909 | PubTator, text mining | PubMed |
| Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer. | Biochem Genet | 2025 | 38683465 | PubTator, text mining | PubMed |
| A Novel KIF4A-related Model for Predicting Immunotherapy Response and Prognosis in Kidney Renal Clear Cell Carcinoma. | Comb Chem High Throughput Screen | 2025 | 38357945 | PubTator, text mining | PubMed |
| Decoding oral cancer: insights from miRNA expression profiles and their regulatory targets. | Front Mol Biosci | 2024 | 39935706 | PubTator, text mining | PubMed |
| The bioinformatics analysis and experimental validation of the carcinogenic role of EXO1 in lung adenocarcinoma. | Front Oncol | 2024 | 39777332 | PubTator, text mining | PubMed |
| Corrigendum: The impact of non-coding RNAs in the epithelial to mesenchymal transition. | Front Mol Biosci | 2024 | 39722893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=7